Amcad Biomed (ROCO:4188) Ending Cash Position : NT$17.76 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Amcad Biomed Ending Cash Position?

Amcad Biomed's Ending Cash Position for the quarter that ended in Dec. 2024 was NT$17.76 Mil.

Amcad Biomed's quarterly Ending Cash Position increased from Jun. 2024 (NT$24.96 Mil) to Sep. 2024 (NT$25.13 Mil) but then declined from Sep. 2024 (NT$25.13 Mil) to Dec. 2024 (NT$17.76 Mil).

Amcad Biomed's annual Ending Cash Position declined from Dec. 2022 (NT$47.04 Mil) to Dec. 2023 (NT$29.66 Mil) and declined from Dec. 2023 (NT$29.66 Mil) to Dec. 2024 (NT$17.76 Mil).

Amcad Biomed Ending Cash Position Historical Data

The historical data trend for Amcad Biomed's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amcad Biomed Ending Cash Position Chart

Amcad Biomed Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

59.65

58.51

47.04

29.66

17.76

Amcad Biomed Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															29.66	26.35	24.96	25.13	17.76

Amcad Biomed Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Amcad Biomed's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	29.658	+	-11.902
	=	17.76

Amcad Biomed's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	25.126	+	-7.37
	=	17.76

Amcad Biomed Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Amcad Biomed's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Amcad Biomed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Amcad Biomed Corp (ROCO:4188) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 167, Fuxing North Road, 5th Floor, Zhongshan District, Taipei, TWN, 104

Website

https://www.amcad.com.tw

Amcad Biomed Corp develops computer-aided detection and diagnosis(CADe/CADx) software devices. Its product pipeline includes AmCAD-UT Detection, AmCAD-UV, AmCAD and AmCAD-UO. The company's geographical segments include Taiwan, China, and other countries, out of which the majority of the revenue is generated from Europe. The company has two segments: Medical diagnostic software: which is responsible for the development and sales of smart medical imaging diagnostic software device and Precision medical equipment: which is responsible for research, development, manufacturing and sales of high-end ultrasonic probes.

Amcad Biomed Headlines

No Headlines